In addition, it has been reported that increased tumor-infiltrating DCs and upregulated their CD86 expression in vivo lead to increased tumor-infiltrating CD8+ T cells and enhanced PD-L1 and MHC class I expression on tumor cells (35). Here, CD86 is linked to neoplasm.